OneMedNet Corp
ONMDNasdaq
$0.68
↓ -1.5%Jul 17 close · end-of-day
Price
1Y↑ +19.5%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$37.6M
Enterprise Value
$37.5M
P/E
—
P/S
28.5
P/B
—
EV/EBITDA
—
PEG
—
FCF Yield
-19.1%
Dividend Yield
—
Revenue (TTM)
$1.3M
Net Income (TTM)
-$3.4M
Free Cash Flow (TTM)
-$7.2M
Gross Margin
-50.0%
Operating Margin
-758.4%
Net Margin
-254.3%
ROE
82.2%
ROIC
—
Debt / Equity
-0.0
Net Cash
$57,000.00
Return 1Y
+25.2%
Company profile
Data Knights Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on businesses in the data centers and internet technology sectors.
- CEO
- Barry Anderson
- Sector
- Services
- Industry
- Business Services
- Employees
- 2
- Website
- N/A
Management & directors
- Green AaronChief Executive Officer
- Yu JeffreyChief Medical Officer
Roles derived from SEC Form 4 filings.
Earnings
ONMD Q 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$96,000.00↓ -29.9%
Diluted EPS-$0.04↓ -33.3%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $1.2M | $1.0M | $643,000.00 | $1.4M |
| Gross profit | -$360,000.00 | -$129,000.00 | -$281,000.00 | -$503,000.00 |
| Operating income | -$7.7M | -$6.9M | -$9.6M | -$9.7M |
| Net income | -$30.5M | -$33.8M | -$10.1M | -$2.8M |
| Diluted EPS | -$7.66 | -$4.65 | -$0.36 | -$0.06 |
| Operating cash flow | -$4.7M | -$4.8M | -$7.0M | -$7.5M |
| Free cash flow | -$4.8M | -$4.8M | -$7.0M | -$7.5M |
| Gross margin | -31.2% | -12.6% | -43.7% | -37.0% |
| Operating margin | -669.1% | -671.2% | -1493.8% | -711.3% |
| Net margin | -2641.0% | -3308.5% | -1575.3% | -206.1% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $227,000.00 | $142,000.00 | $26,000.00 | $137,000.00 | $155,000.00 | $177,000.00 | $890,000.00 | $96,000.00 |
| Gross profit | -$102,000.00 | -$84,000.00 | -$26,000.00 | -$224,000.00 | -$241,000.00 | -$222,000.00 | $184,000.00 | -$380,000.00 |
| Operating income | -$2.5M | -$2.3M | -$2.7M | -$2.2M | -$2.1M | -$2.2M | -$3.1M | -$2.6M |
| Net income | -$3.6M | -$2.1M | -$2.4M | -$1.9M | $3.0M | -$741,000.00 | -$3.1M | -$2.5M |
| Diluted EPS | -$0.14 | -$0.07 | -$0.07 | -$0.06 | $0.07 | -$0.01 | -$0.06 | -$0.04 |
| Operating cash flow | -$1.5M | -$1.9M | -$2.0M | -$1.9M | -$2.4M | -$1.6M | -$1.7M | -$1.5M |
| Free cash flow | -$1.5M | -$1.9M | -$2.0M | -$1.9M | -$2.4M | -$1.6M | -$1.7M | -$1.5M |
| Gross margin | -44.9% | -59.2% | -100.0% | -163.5% | -155.5% | -125.4% | 20.7% | -395.8% |
| Operating margin | -1081.1% | -1645.1% | -10438.5% | -1623.4% | -1331.0% | -1262.7% | -353.4% | -2658.3% |
| Net margin | -1581.1% | -1449.3% | -9126.9% | -1388.3% | 1923.9% | -418.6% | -352.8% | -2555.2% |
Company news
Apr 22, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-23 | Yu Jeffrey· Chief Medical Officer | Buy | 158,730 | $0.63 | $99,999.90 | filing |
| 2026-06-23 | Green Aaron· Chief Executive Officer | Buy | 36,650 | $0.57 | $21,011.45 | filing |
| 2026-06-16 | Yu Jeffrey· Chief Medical Officer | Buy | 172,414 | $0.58 | $100,000.12 | filing |
| 2026-06-15 | Green Aaron· Chief Executive Officer | Buy | 18,702 | $0.54 | $10,091.60 | filing |
| 2026-06-12 | Kosasa Thomas | Buy | 158,730 | $0.63 | $99,999.90 | filing |
| 2026-06-12 | Green Aaron· Chief Executive Officer | Buy | 36,920 | $0.56 | $20,605.05 | filing |
| 2026-05-18 | Kosasa Thomas | Buy | 268,817 | $0.93 | $249,999.81 | filing |
| 2026-04-23 | Kosasa Thomas | Buy | 280,898 | $0.89 | $249,999.22 | filing |
| 2026-04-01 | Yu Jeffrey· Chief Medical Officer | Buy | 903,614 | $0.83 | $749,999.62 | filing |
| 2026-04-01 | Yu Jeffrey· Chief Medical Officer | Award | 219,429 | $0.83 | $182,126.07 | filing |
| 2026-02-06 | Kosasa Thomas | Buy | 595,238 | $0.84 | $499,999.92 | filing |
| 2025-11-26 | Yu Jeffrey· Chief Medical Officer | Award | 45,000 | $0.00 | $0.00 | filing |
| 2025-11-26 | Alleyne Kenneth | Award | 38,219 | $0.00 | $0.00 | filing |
| 2025-11-24 | Yu Jeffrey· Chief Medical Officer | Award | 200,000 | $0.00 | $0.00 | filing |
| 2025-11-18 | Green Aaron· Chief Executive Officer | Sale | 61,555 | $1.20 | $73,902.93 | filing |
| 2025-10-22 | Green Aaron· Chief Executive Officer | Sale | 64,767 | $2.23 | $144,721.86 | filing |
| 2025-09-25 | Yu Jeffrey· Chief Medical Officer | Buy | 1,250 | $1.03 | $1,287.50 | filing |
| 2025-09-24 | Yu Jeffrey· Chief Medical Officer | Buy | 17,200 | $1.02 | $17,544.00 | filing |
| 2025-09-23 | Yu Jeffrey· Chief Medical Officer | Buy | 5,700 | $0.93 | $5,301.00 | filing |
| 2025-09-22 | Yu Jeffrey· Chief Medical Officer | Buy | 400 | $0.95 | $380.00 | filing |
| 2025-09-19 | Yu Jeffrey· Chief Medical Officer | Buy | 1,250 | $0.89 | $1,112.50 | filing |
| 2025-09-18 | Yu Jeffrey· Chief Medical Officer | Buy | 700 | $0.91 | $637.00 | filing |
| 2025-09-05 | Yu Jeffrey· Chief Medical Officer | Buy | 2,100 | $0.86 | $1,806.00 | filing |
| 2025-09-04 | Yu Jeffrey· Chief Medical Officer | Buy | 11,810 | $0.87 | $10,274.70 | filing |
| 2025-09-03 | Yu Jeffrey· Chief Medical Officer | Buy | 11,670 | $0.81 | $9,452.70 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.